Buy
Market
🔥
Prediction Market

Harvard Holds Bitcoin ETF Stake at 3.04 Million Shares

Harvard Management kept its 3.04 million IBIT shares steady in Q3, a position now worth $110.6 million after bitcoin's slide.

16/11/2026 16:1213 min read

Harvard Management Company kept its stake in BlackRock's iShares Bitcoin Trust unchanged at 3,044,612 shares during the third quarter. That position was valued at $144.1 million as of Sept. 30 and is now worth roughly $110.6 million following a decline in bitcoin's price.

The university's endowment manager disclosed the holding in a Form 13F filed Friday, covering the three months ended Sept. 30. The share count matches what Harvard reported on June 30 and March 31. At 10:40 a.m. ET on Monday, IBIT was trading at $36.32, placing the stake at about $110.6 million, a paper loss of roughly $33.6 million, or 23%, from the valuation in the filing. The Sept. 30 closing price of $47.34 aligns with the price implied by the reported value.

The same 3,044,612 shares were valued at $101.4 million on June 30 and $117.0 million on March 31, meaning the position rose in value during the third quarter as bitcoin recovered, then gave back much of that gain after the quarter ended. Even after the November decline, the stake remains worth more than it was at midyear.

IBIT was Harvard's eighth-largest position among 18 holdings in a 13F portfolio valued at $3.95 billion, representing about 3.6% of that publicly disclosed book of U.S. securities, which excludes the rest of the endowment. The largest holding was Space Exploration Technologies, reported at $1.29 billion. Taiwan Semiconductor Manufacturing came second, at $616.5 million. That ranking marks a sharp shift from late 2025, when the bitcoin ETF was Harvard's largest publicly disclosed position.

First bought in 2025, then cut, then held

Harvard first reported an IBIT position in its filing for the quarter ended June 30, 2025: 1,906,000 shares worth $116.7 million. The fund had not been listed in earlier 13Fs, including the report for March 31, 2025. By Sept. 30, 2025, Harvard had tripled the stake to 6,813,612 shares, valued at $442.9 million, making IBIT its largest public holding.

The endowment trimmed that position by about 21% in the fourth quarter of 2025, to 5,353,612 shares worth $265.8 million, and opened a first stake in BlackRock's iShares Ethereum Trust of 3,870,900 shares, valued at $86.8 million. It cut the bitcoin ETF again in the first quarter of 2026, by about 2.31 million shares, or 43%, to the 3,044,612 shares it still reported on Sept. 30, and sold the Ethereum fund entirely. The latest filing lists no other bitcoin or crypto ETFs. The remaining IBIT position is still larger, in share terms, than the 1.91 million shares Harvard first disclosed.

Gold now outweighs the bitcoin ETF

Harvard's gold ETFs are now much larger than its bitcoin position. The same 13F lists 1,161,000 shares of SPDR Gold Shares worth $442.2 million, the portfolio's third-largest holding, and 1,980,085 shares of the iShares Gold Trust worth $154.6 million. Combined, the two gold funds were valued at $596.8 million, more than four times the IBIT stake. The iShares Gold Trust share count was unchanged from June 30. The SPDR Gold Shares position jumped from 58,862 shares at midyear.

Bitcoin traded near $64,200 as of 10:40 a.m. ET Monday, down about 17% in November from an Oct. 31 close near $77,400, and down about 23% from about $83,550 at the end of September. Since the quarter closed, U.S. spot bitcoin ETFs have been seeing heavy redemptions. IBIT bled about $2 billion over nine straight sessions through mid-November, and the funds as a group extended their outflow streak to seven sessions through Friday, losing about $1.91 billion since Nov. 5.

The 13F is a snapshot of holdings as of Sept. 30. It does not show whether Harvard bought or sold any IBIT shares in October or November.

Share to

Disclaimer: this article comes from third-party media and is provided for reference only. It does not constitute investment advice. Crypto and other financial products carry significant price volatility risk, so please make your own decisions carefully.

Related articles